Johnson and Johnson, drug maker, has hit more issues. The FDA decided they needed to come to Lancaster, Penn and shut down a medicinal manufacturing plant of Johnson and Johnson. The plant didn’t pass an inspection that was done and can’t reopen until one more inspection is passed. Johnson and Johnson has already suffered some high profile setbacks over the past a number of months, on the heels of a large recall of children’s Motrin and Tylenol products.
Lancaster PA plant closes its doors
Merch Consumer Pharmaceuticals is hurt by this also considering the plant, according to CNN Money, was joined with them and Johnson and Johnson. FDA guidelines weren’t being met which is what the form 483 given to the plant meant. In the last few months, Johnson and Johnson has had another plant close, and this plant closing meant a setback within the Johnson and Johnson – Merck relationship. The plant manufactured Mylanta, Immodium and Pepcid.
J and J closes one more plant
In May, Johnson and Johnson was ordered by the FDA to close a Fort Washington, Penn., plant for non-compliance with codes. Children’s Motrin and Tylenol, the same ones within the recall, were made at that plant. McNeil Consumer Healthcare ran the Fort Washington plant for Johnson and Johnson, and they have just laid off 300, or two thirds, or their employees. The plant had to close down since the Motrin and Tylenol being recalled in 2009 were contaminated. May 6, 2010, 130 more bottles of Motrin and Tylenol were recalled because of a new Tylenol recall.
Drugs needed by McNeil executives
McNeil Consumer Healthcare has been lambasted by the FDA on an almost quarterly basis for years. McNeil and also the Fort Washington plant are continuously under investigation since 2003, and McNeil has issued five recalls of products in the last 8 months. Consumers probably want to know if safe medicine is even available anymore.
Sources
Lancaster PA plant closing
money.cnn.com/2010/07/16/news/companies/johnson_fda_new_inspection_report/index.htm
Fort Washington plant closing
money.cnn.com/2010/06/22/news/companies/tylenol_plant_inspection_history/index.htm?postversion=2010062318